Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Clarke

Clarke Berdan, Ii, Granville, OH US

Patent application numberDescriptionPublished
20080314275Method And Apparatus For Manufacturing Panel Products Including A Printed Surface - Provided are a method and apparatus for fabricating a panel product including a board, panel or substrate having at least one surface on which a decorative image and alignment marks corresponding to an image data file are applied. The alignment marks and the image data file are then used to align an intermediate product with one or more cutting devices. Once aligned, the original image data file or a transformed version of the image data file is used to control cutters or other tools for removing waste portions of the panel product. The panel product may then be subjected to additional processing, particularly with regard to edge treatments, to obtain a final panel product.12-25-2008

Clarke Mcallistor, Eugene, OR US

Patent application numberDescriptionPublished
20090314829Systems, Methods, and Devices for Replication of Data onto Wireless Sensors - In one embodiment the present invention comprises a bar code scanner and an encoder for commissioning RFID transponders and includes a housing encasing a motor assembly, an RFID interrogator, a wireless communication means for transferring instructions and data from and to a remote host, on-board memory, a processor, and an antenna with corresponding mechanism to encode and verify a programmable RFID transponder on a conveyance web. The present invention further includes novel methods for commissioning RFID transponders, as well as methods for recycling and reusing the protective enclosure.12-24-2009

Clarke Reberg, Holland, MI US

Patent application numberDescriptionPublished
20090208901Dental implement for tooth restoration - A dental implement comprising a biasing ring and a pair of opposing tines. The biasing ring includes a substantially hoop-like configuration terminating at two opposing ends which are spaced apart from each other a distance. The pair of opposing tines extend inwardly from each of the two ends of the biasing ring toward each other. Each of the pair of opposing tines is coupled to the respective opposing end about a central region thereof and extends radially outwardly therefrom. Each tine includes a front face having opposing sides, a top end and a bottom end. The front face is defined by two inwardly inclined surfaces which start at the opposing sides and incline inwardly toward each other and intersect to form a peak that extends at least partially between the top end and the bottom end of the front face. The peaks of the opposing tine assemblies face each other.08-20-2009
20110070555Matrix band for dental applications - A matrix band for dental applications comprising a base material and a coating. The base material has an outer surface and a tooth contact surface as well as a perimeter. The coating is applied to the tooth contact surface and extends to the perimeter of the tooth contact surface. The coating is a fluorinated ethylene propylene, polytetrafluoroethylene and polyether sulfone.03-24-2011

Clarke Retzer, Van Nuys, CA US

Patent application numberDescriptionPublished
20120088220METHOD AND SYSTEM FOR ASSIGNING A TASK TO BE PROCESSED BY A CROWDSOURCING PLATFORM - A method and system for applying a task to a crowdsourcing platform for processing are disclosed. For example, a method forwards the task having a question to the crowdsourcing platform, and receives a plurality of answers to the question, wherein the plurality of answers is provided by a plurality of workers associated with the crowdsourcing platform. The method analyzes the plurality of answers on a per-worker basis to determine an adjustment, and applies the adjustment to the plurality of answers.04-12-2012

Clarke Slemon, Portland CA

Patent application numberDescriptionPublished
20080305508Methods of screening for compounds that modulate TAFIa activity, compounds, and methods of using the compounds - Provided are methods of screening compounds for any aspirin-related activity other than TAFI inhibition, and also for non-inhibition of TAFI. Compounds identified by the screening methods can be used to treat, prevent or manage in a patient pain, fever, colon cancer, pancreatic cancer or an inflammatory, platelet aggregation, fibrinolytic or hemorrhagic disease or disorder. Also provided is a method of evaluating test compounds for TAFI inhibitory activity wherein the TAFI inhibitory activity of these test compounds is compared to the TAFI inhibitory activity of aspirin or its derivatives or metabolites. Further provided is a method of treating, preventing or managing in a patient, a hemorrhagic or thrombotic disease or disorder with high dose aspirin or aspirin derivatives or metabolites. Also contemplated is a method of treating, preventing or managing in a patient, pain, fever, colon cancer, pancreatic cancer or an inflammatory, platelet aggregation, fibrinolytic or hemorrhagic disease or disorder comprising administering aspirin or a derivative thereof or any other therapeutic having at least one desired therapeutic or prophylactic activity of aspirin to a patient in need thereof and administering to the patient a factor that promotes TAFIa activity, e.g. stabilized TAFIa, to ameliorate one or more adverse side effects of the therapeutic. Compounds identified by the methods of the invention are also provided.12-11-2008
20100310540METHODS OF SCREENING FOR COMPOUNDS THAT MODULATE TAFIA ACTIVITY, COMPOUNDS, AND METHODS OF USING THE COMPOUNDS - Provided are methods of screening compounds for any aspirin-related activity other than TAFI inhibition, and also for non-inhibition of TAFI. Compounds identified by the screening methods can be used to treat, prevent or manage in a patient pain, fever, colon cancer, pancreatic cancer or an inflammatory, platelet aggregation, fibrinolytic or hemorrhagic disease or disorder. Also provided is a method of evaluating test compounds for TAFI inhibitory activity wherein the TAFI inhibitory activity of these test compounds is compared to the TAFI inhibitory activity of aspirin or its derivatives or metabolites. Further provided is a method of treating, preventing or managing in a patient, a hemorrhagic or thrombotic disease or disorder with high dose aspirin or aspirin derivatives or metabolites. Also contemplated is a method of treating, preventing or managing in a patient, pain, fever, colon cancer, pancreatic cancer or an inflammatory, platelet aggregation, fibrinolytic or hemorrhagic disease or disorder comprising administering aspirin or a derivative thereof or any other therapeutic having at least one desired therapeutic or prophylactic activity of aspirin to a patient in need thereof and administering to the patient a factor that promotes TAFIa activity, e.g. stabilized TAFIa, to ameliorate one or more adverse side effects of the therapeutic. Compounds identified by the methods of the invention are also provided.12-09-2010

Patent applications by Clarke Slemon, Portland CA

Clarke Taylor, Emeryville, CA US

Patent application numberDescriptionPublished
20100184754QUINOLINONE DERIVATIVES - Organic compounds having the formulas I and II are provided where the variables have the values described herein.07-22-2010